http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060134191-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
filingDate 2005-03-29^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662ff3f37abec100fb34e639dd6d171d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80172bef4dffce387966fb132792647f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a8740958191e076d958c773d8d20f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3a3fa32288f1f323a7b5e3170e849c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c15daa6591d9bb29b04fed6fe954d0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00302cc9368f1f21c2f0b381ced32d95
publicationDate 2006-12-27^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060134191-A
titleOfInvention Use of PPR Delta Agonists to Treat Myelin Deprivation Disease
abstract A method of treating myelin deprivation disease in a patient in need of treatment with an effective amount of a PPAR delta agonist is described. Myelin deprivation diseases that can be effectively treated by this method include multiple sclerosis, Charco-Marie-Tus disease, Felicitus-Mertzsbach's disease, encephalomyelitis, optic nephritis, adrenal protein dystrophy, Gillian-Barre syndrome and myelin-forming glioblastoma Including but not limited to diseases including injured spinal cord injury, neuropathy and nerve damage.
priorityDate 2004-04-01^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476879

Showing number of triples: 1 to 26 of 26.